is tirzepatide a glp-1 Associated with Lower POAG, OHT Risk Compared with Other Drugs Semaglutide Vs Tirzepatide | GLP

& Szegedy, C

In general, gastrointestinal side effects, especially constipation, may persist even as other symptoms diminish over time and appear to occur less frequently with long-acting GLP-1 RAs [118]

Overall, studies have shown that these medications have an established safety profile in T1D, with only a modest effect on HbA1c, but significant weight loss, and a reduction in TDI

Risk factors include central adiposity, dyslipidemia, hypertension, and sedentary lifestyle

10.1042/CS20040302 [DOI] [PubMed] [Google Scholar] 27.Yu DM, Slaitini L, Gysbers V, Riekhoff AG, Kahne T, Knott HM, et al

However, these medications offer a range of additional health benefits that extend beyond shedding pounds